Brucellosis diagnostic criteria

Revision as of 18:17, 9 January 2017 by Vishal (talk | contribs)
Jump to navigation Jump to search

Brucellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Brucellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Principles of diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT Scan

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Brucellosis diagnostic criteria On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Brucellosis diagnostic criteria

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Brucellosis diagnostic criteria

CDC on Brucellosis diagnostic criteria

Brucellosis diagnostic criteria in the news

Blogs on Brucellosis diagnostic criteria

Directions to Hospitals Treating Brucellosis

Risk calculators and risk factors for Brucellosis diagnostic criteria

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Danitza Lukac

Overview

There is no specific diagnostic criteria for Brucellosis, Diagnosis is based on history of potential exposure, presentation consistent with the disease,Supporting laboratory findings.[1]

Diagnostic Criteria

There is no specific diagnostic criteria for Brucellosis, Diagnosis is based on:[2][3][4][5][6][7][8][9][10][11][12]

  • History of potential exposure
  • Presentation consistent with the disease
  • Supporting laboratory findings
Diagnosis of brucellosis
History of potential exposure
  • Living or travelling to Brucellosis endemic countries
  • Consuming unpasteurized dairy products or raw meat products
  • Unsafe hunting practices
  • Occupational risks such as slaughther house workers, meat-packing employees, and veterinarian
presentation consistent with the disease An illness characterized by acute or insidious onset of fever and one or more of the following:
Supporting laboratory findings
  • Definitive:
    • Culture and identification of Brucella spp. from clinical specimens
    • Evidence of a fourfold or greater rise in Brucella antibody titer between acute- and convalescent-phase serum specimens obtained greater than or equal to 2 weeks apart
  • Presumptive:
    • Brucella total antibody titer of greater than or equal to 160 by standard tube agglutination test (SAT) or Brucella microagglutination test (BMAT) in one or more serum specimens obtained after onset of symptoms
    • Detection of Brucella DNA in a clinical specimen by PCR assay

Other non-specific findings may include:

  • Complete blood count: Normal or low with relative lymphocytosis. Low platelets may be reported
  • Hemoglobin: Mild anemia is documented
  • Normal or elevated ESR
  • Normal or elevated C-reactive protein levels
  • Raised fibrinogen degraded products

Reference

  1. Brucellosis 2010 Case Definition. CDC. http://wwwn.cdc.gov/nndss/conditions/brucellosis/case-definition/2010/. Accessed on February 2, 2016
  2. Brucellosis "Dennis Kasper, Anthony Fauci, Stephen Hauser, Dan Longo, J. Larry Jameson, Joseph Loscalzo"Harrison's Principles of Internal Medicine, 19e Accessed on December 9, 2016
  3. Colmenero JD, Reguera JM, Martos F, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75:195.
  4. Mantur BG, Amarnath SK, Shinde RS. Review of clinical and laboratory features of human brucellosis. Indian J Med Microbiol 2007; 25:188.
  5. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med 2005; 352:2325.
  6. Doganay M, Aygen B. Human brucellosis: An overview. Int J Infect Dis 2003; 7:173.
  7. Young EJ. Brucellosis: current epidemiology, diagnosis, and management. Curr Clin Top Infect Dis 1995; 15:115.
  8. Aygen B, Doganay M, Sumerkan B, et al. Clinical manifestations, complications and treatment of brucellosis: a retrospective evaluation of 480 patients. Med Malad Infect 2002; 32:485.
  9. Geyik MF, Gür A, Nas K, et al. Musculoskeletal involvement of brucellosis in different age groups: a study of 195 cases. Swiss Med Wkly 2002; 132:98.
  10. Mousa AM, Bahar RH, Araj GF, et al. Neurological complications of brucella spondylitis. Acta Neurol Scand 1990; 81:16.
  11. Pappas G, Bosilkovski M, Akritidis N, et al. Brucellosis and the respiratory system. Clin Infect Dis 2003; 37:e95.
  12. Herrick JA, Lederman RJ, Sullivan B, et al. Brucella arteritis: clinical manifestations, treatment, and prognosis. Lancet Infect Dis 2014; 14:520.